Commercial Fibrinogen, Autogenous Plasma, Whole Blood and Cryoprecipitate for Coagulum Pyelolithotomy: A Comparative Study
- 1 March 1978
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 119 (3) , 310-311
- https://doi.org/10.1016/s0022-5347(17)57473-x
Abstract
Coagulation pyelolithotomy provides an effective means to remove multiple calculi from the renal collecting system. The strength of the coagulum is directly proportional to the concentration of fibrinogen and inversely proportional to the concentration of thrombin. It may become necessary to use plasma from the patient as the source of fibrinogen. By the process of cryoprecipitation fibrinogen levels can be increased about 10-fold, yielding clots of greater tensile strength than would be obtained from non-concentrated plasma.This publication has 13 references indexed in Scilit:
- Coagulum Pyelolithotomy using Autogenous Plasma and Bovine ThrombinJournal of Urology, 1976
- Determinants of Factor VIII Recovery in CryoprecipitateTransfusion, 1975
- The coagulum pyelolithotomyBritish Journal of Surgery, 1973
- Coagulum PyelolithotomyJournal of Urology, 1955
- Coagulum Pelviolithotomy; An Improved TechniqueJournal of Urology, 1952
- Coagulum pyelolithotomyThe American Journal of Surgery, 1950
- Experiences with Fibrin Coagulum in PyelolithotomyJournal of Urology, 1949
- The Use of a Fibrinogen Coagulum in PyelolithotomyJournal of Urology, 1946
- The Properties of Human Fibrinogen Coagulum—Preliminary ReportJournal of Urology, 1943
- THE USE OF AN INTRAPELVIC COAGULUM IN PYELOLITHOTOMYSouthern Medical Journal, 1943